According to a new market research report published by Transparency Market Research “Regenerative Medicine (Bone and Joint) Market (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019” the global regenerative medicine (bone and joint) market was valued at USD 2.6 billion in 2012 and is estimated to reach a market worth of USD 6.5 billion in 2019 growing at a CAGR of 12.8% from 2013 to 2019.

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint) market. However, ethical issues pertaining to stem cell therapy and fear of disease transmission due to allogeneic bone implantation are considered as market hindering factors during the study period. Companies operating in this market focus on investing in emerging economies of Asia-Pacific such as India, China, Japan and South Korea. These economies represent huge potential for various bone and joint reconstructive products due to rising healthcare expenditure and presence of large patient pool suffering from arthritis disorder (rheumatoid arthritis).

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. However, high cost associated with biomaterials is a factor that would restrict the global market demand to some extent during the study period.

In addition, based on applications the global market for regenerative medicine (bone and joint) is segmented as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. However, post implantation rejection associated with bone graft substitute is considered as a crucial factor that would restrict the global market demand of bone graft substitute.

On the basis of geography, the regenerative medicine (bone and joint) market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America accounted for the largest market share for regenerative medicine (bone and joint) globally in 2012 owing to increase in orthopedic reconstructive surgeries and introduction of technologically advanced medical devices and products. According to the American Academy of Orthopedic Surgeons (AAOS), prevalence of Lumbar Spinal Stenosis (LSS) is increasing with rise in elderly population and is estimated that approximately 2.4 million Americans would be affected by LSS by 2021. It has also stated that in 1990 approximately 129,000 Total Knee Arthroplasty (TKA) surgeries were performed in the U.S.

Europe accounted for the second largest share in the global regenerative medicine (bone and joint) market in 2012. Large geriatric population base is one of the important factors driving the growth of regenerative medicine bone and joint application market in this region. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019, due to large pool of potential reconstructive surgery patients and strong support from federal government. Additionally, companies are expecting large revenue with sufficient market penetration from Asia-Pacific region and thereby focusing on increasing investments in this region. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region.

Major market players having presence in the global regenerative medicine (bone and joint) market include DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler), Orthofix, Inc. (Trinity Evolution) and NuVasive, Inc. (Osteocel Plus). 

Browse the full Regenerative Medicine (Bone and Joint) Market report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

Regenerative Medicine (Bone and Joint) Market, by Application

Regenerative Medicine (Bone and Joint) Market, by Geography

According to MD of Card Processing Advisory Service (CPRAS), said that as part of this short survey, the company had requested information from 280 councils about their compliance with PCI. CPRAS is a company that helps customers keep tabs on their card payment costs, and to cut them if they are found to be high.

However, only 44 councils responded to the company’s requests, which likely indicate the lack of compliance that exists in this sector. Of the 44 councils that responded, only 11 said they were in compliance. 26 councils acknowledged that they weren’t currently complying with PCI. The remaining seven firms said that they were yet to be certified for PCI compliance, though they were still following the standards.

The company made use of the Freedom of Information Act (FOIA) to obtain information for this survey. From the results, it is evident that IT channel companies could tap this unmet need in the public sector. Opportunities exist in offering assistance or in developing and deploying the right products geared towards compliance.

Hallewell said that the results of non-compliance could be dangerous, as information of individuals could land in the hands of cyber criminals. More importantly, it could affect the critical day-to-day functioning of councils, leading to catastrophic effects. In such a case, councils would also be unable to accept card payments – subjecting them to the payment of fines.

Transparency Market Research has released a new market report titled “Carbon Black Market for Textile Fibers (Polyester, Nylon, Acrylic and Others) for Apparels, Home Textiles and Other End-users – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” According to the report, the global carbon black market for textile fibers was valued at USD 597.2 million in 2012 and is expected to reach USD 964.4 million by 2019, growing at a CAGR of 7.1% from 2013 to 2019.

Consumption of cotton has been declining globally primarily due to the high cost and low strength of cotton. Furthermore, the increasing demand for arable land for the production of other profitable crops has led to a decrease in the production of cotton. This decline in consumption of cotton has resulted in an increase in demand for synthetic fibers. This is one of the growth drivers for the carbon black market for textile fibers as carbon black is used mainly in the synthetic fibers industry. Other major factors driving demand for carbon black for textile fibers include high growth in the polyester fiber market. Major raw materials employed in the production of carbon black are derivatives of crude oil which have a high carbon content. Volatility in raw material prices and increase in the number of stringent regulations due to several environmental and health hazards associated with carbon black have been restraining the growth of the carbon black for textile fibers market. Increase in research and development activities to develop efficient techniques to produce carbon black from bio-based sources are expected to offer huge growth opportunities in the market.

The carbon black market for textile fibers has been bifurcated into four product segments: polyester, nylon, acrylic and others. Polyester is the largest product segment in the carbon black market for textile fibers and accounted for over 55% share of the global market in 2012. Based on end-users, the carbon black market for textile fibers is bifurcated into three major segments: home textiles, apparels and others. The apparels segment is the most dominant product segment for carbon black market for textile fibers and accounted for around 54% of the global market in 2012. Moreover, the home textiles segment, that includes carpets and sheets, is also a major segment of the carbon black market for textile fibers. Furthermore, the others segment that includes automotive and agricultural textiles is expected to be the fastest growing end-user segment of the carbon black market for textile fibers in the future.


Asia Pacific dominated the global demand for carbon black for textile fibers and accounted for 58.2% of the global market in 2012. This trend is anticipated to continue during the forecast period. Major industry participants include Cabot Corporation, Philips Carbon Black Ltd, Birla Carbon and Mitsubishi Chemical Corporation.

According to these latest guidelines, the focus will now be on promoting independent IT applications in China, with a view to strengthening military information security. This was reported by Shanghai-based China Business News.

Today, a country’s chip making industry speaks volumes about its competitiveness on the industrial and technological front. This is also the reason why China is laying greater emphasis on its independent IT applications. The country has plans to further strengthen its information security systems, and the new military guidelines are geared towards this.

According to a market research expert, the semiconductor manufacturing sector in China will witness a sea change in the five years ahead. The timing seems to be right, as the chip making industry in China is now reaching a stage of maturity, and will be able to respond more effectively to these guideline changes. Analysts state that chips produced domestically will become more conspicuous in the Chinese market beginning late 2014.

China is under tremendous pressure to emerge as a leader in the cyber security domain, as many other countries are competing for the strategic position. However, producing chips domestically is not an easy option for China, as its semiconductor manufacturing sector is yet to develop fully. A shortage of high-end chips in China is evident, and more capital investments in this sector are required.

According to a new market report published by Transparency Market Research “Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global biological drugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 287,139.7 million in 2020.

The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronic diseases and increase in the global geriatric population. Biological drugs are used in treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Moreover, various government associations are also promoting the usage of biological drugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.

On the other hand, high cost of biological drugs and patent expiry of blockbuster drugs impede the growth of the market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the market. As a result, biological drugs market is expected to grow a CAGR of about 10.1% during 2014-2020.

North America is the largest market for biological drugs. Increased use of biological drugs for the treatment of diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biological drugs market in the region. The American Center for Biological Medicine (ACBM) is one of the largest biological medicine clinics in the U.S. Similarly, the European biological drugs market is growing rapidly due to increased usage of biological drugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases.

Browse the full Biological Drugs Market report: http://www.transparencymarketresearch.com/biological-drugs-market.html

In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries, supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting growth of the biological drugs market by increased investment on biotech companies for construction of R&D and manufacturing facilities. Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck & Co., Inc. are the some of the leading players in the global biological drugs market. Other major players of biological drugs market include Abbott Laboratories, Biogen Idec and Amgen Inc.


The global market of biological drugs is segmented as follows:

Biological Drugs Market, By Therapeutic Protein

Biological Drugs Market, By Monoclonal Antibody (mAb)

Biological Drugs Market, By Vaccine

Biological Drugs Market, by Geography

According to a new market report published by Transparency Market Research "Low-calorie Food Market, Global Forecast, Market Share, Size, Growth and Industry Analysis, 2014 - 2019," the global Low-calorie food market was valued at USD 7,418.6 million in 2013 and is expected to grow at a CAGR of 5.9% from 2014 to 2019, to reach an estimated value of USD 10,414.7 million in 2019.

In recent times, obesity has become one of the most challenging health problems in the world. According to the WHO, the number of overweight children under the age of five in 2010 was around 42 million, globally. Obese people are more likely to develop diseases such as diabetes and cardiovascular diseases at a young age. Obesity rate is the highest in the U.S., as around 36.5% of the total U.S. population is obese. The U.K. (24.8%) has the highest obese population in Europe, while Australia (28.3%) leads in the Asia-Pacific region. High obesity rate among children is a major concern for parents. Obesity is also a major concern in adults, as is the rising number of diabetes cases globally. The WHO noted that around 347 million people worldwide had diabetes in 2013, these factors led to the increase in demand of low calorie food over the last few years. The demand for low-calorie food is also increasing due to changing lifestyle, increasing number of health conscious people, and growing consumer confidence in low-calorie products due to their natural claims.

The emerging markets such as India, China and Brazil, have rising number of diabetes patients, fuelling the demand for low-calorie food. For instance, low-calorie products such as Sugar Free, Glucerna SR, and Splenda tablets offer opportunity for Low-calorie Food Manufacturers in these regions.

Based on application, the low calorie food market is broadly classified under, food, beverages, healthcare, tabletop and others. Whereas on the basis product segment, "Aspartame", "Sucralose", "Stevia", "Saccharin" and "Cyclamate" are the broad categories. Aspartame is one of the most widely used artificial sweeteners. In the recent scenario, sucralose is gaining more popularity than aspartame. Growing consumer preferences for all-natural products have created a huge demand for stevia. Due to its growing popularity as a 100% natural sweetener, stevia is giving tough competition to other high-intensity sweeteners such as aspartame, saccharin and sucralose.

The global low-calorie food market was USD 7,418.6 million in 2013. Sucralose is expected to be the fastest growing segment, likely to register a strong growth in the future. Usage of low-calorie food products in the beverages sector is forecasted to increase by 5.9% CAGR from 2014 to 2019. The U.S. is the largest market for low calorie food, followed by the European countries. The developing nations in the Asia-Pacific region are expected to show high growth in the next five years.

Browse the full Low-calorie Food Market report:http://www.transparencymarketresearch.com/zero-calorie-low-calorie-food.html

Some of the major companies operating in the market are PepsiCo Inc., The Coca-Cola Company, Groupe Danone, Bernard Food Industries, Inc., Nestle S.A., Ajinomoto Co., Inc., McNeil Nutritionals, LLC and Cargill, Incorporated.

The Low-calorie food market is segmented as follows:

Low-calorie food Market, by Product Segment

Low-calorie food Market, by application segment

Low-calorie food Market, by Region

Product type segment analyzed in the study include floating production storage and offloading (FPSO), floating storage and offloading (FSO), Tension Leg platform (TLP) and Single Point Anchoring Reservoir (SPAR). In terms of revenue, FPSO was the highest in product segment, accounting for around 63.8% of the total market share in 2012. Companies such as Royal Dutch Shell Plc, Petrobras and ENI are using FPSO to extract crude oil from offshore fields. FSO accounted for a moderate share of the total FPS market, followed by other equipments such as TLP and SPAR.

RoW dominated the global market for floating production systems in 2012. The region constituted the highest percentage of the global FPS market in terms of revenue. RoW is the leading market in terms of demand for FPS as compared to other regions such as Asia Pacific and North America. This is mainly ascribed due to high demand from South American and African countries such as Brazil and South Africa. RoW is anticipated to exhibit the highest growth rate during the forecast period, led by developing economies such as Brazil and South Africa. North America and Asia Pacific accounted for substantial shares of the total FPS market in 2012. The global floating production systems market has witnessed significant growth over the last few years.

Companies such as Bumi Armada Berhad, Hyundai Heavy Industries Co. Ltd, Keppel Offshore & Marine Ltd, Malaysia Marine and Heavy Engineering Berhad, Mitsubishi Heavy Industries Ltd, Samsung Heavy Industries Co. Ltd, SBM Offshore N.V., Teekay Corporation, Technip S.A. and Worley Parsons Limited are likely to dominate the floating production systems market in the coming future.


Floating Production Systems Market: Product Type Analysis

Floating Production Systems Market: Regional Analysis